These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23906791)

  • 1. Antiarrhythmic drugs in atrial fibrillation: do they have a future?
    Angaran P; Dorian P
    Can J Cardiol; 2013 Oct; 29(10):1158-64. PubMed ID: 23906791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic drugs for atrial fibrillation.
    Marinelli A; Capucci A
    Expert Opin Pharmacother; 2011 Jun; 12(8):1201-15. PubMed ID: 21323608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits.
    Camm J
    Int J Cardiol; 2012 Mar; 155(3):362-71. PubMed ID: 21708411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation: pharmacological therapy.
    Patel C; Salahuddin M; Jones A; Patel A; Yan GX; Kowey PR
    Curr Probl Cardiol; 2011 Mar; 36(3):87-120. PubMed ID: 21392636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhythm control of atrial fibrillation in heart failure.
    Heijman J; Voigt N; Abu-Taha IH; Dobrev D
    Heart Fail Clin; 2013 Oct; 9(4):407-15, vii-viii. PubMed ID: 24054474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?
    Morrow JP; Cannon CP; Reiffel JA
    Am Heart J; 2007 Nov; 154(5):824-9. PubMed ID: 17967585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy for atrial fibrillation.
    Musco S; Conway EL; Kowey PR
    Med Clin North Am; 2008 Jan; 92(1):121-41, xi. PubMed ID: 18061001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing the controversy of rate-versus-rhythm control in atrial fibrillation.
    Contractor T; Levin V; Desai R; Marchlinski FE
    Postgrad Med; 2013 Sep; 125(5):7-18. PubMed ID: 24113659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological rhythm control strategy for atrial fibrillation].
    Sasano T; Hirao K
    Nihon Rinsho; 2013 Jan; 71(1):67-71. PubMed ID: 23631174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation: the rate versus rhythm management controversy.
    Camm AJ; Savelieva I
    J R Coll Physicians Edinb; 2012; 42 Suppl 18():23-34. PubMed ID: 22518391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Flecainide for the Treatment of Atrial Fibrillation.
    Echt DS; Ruskin JN
    Am J Cardiol; 2020 Apr; 125(7):1123-1133. PubMed ID: 32044037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New pharmacological approaches to atrial fibrillation.
    Milnes JT; Madge DJ; Ford JW
    Drug Discov Today; 2012 Jul; 17(13-14):654-9. PubMed ID: 22370250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation.
    Singla S; Karam P; Deshmukh AJ; Mehta J; Paydak H
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):12-20. PubMed ID: 21335483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate control versus rhythm control.
    Vidaillet H; Greenlee RT
    Curr Opin Cardiol; 2005 Jan; 20(1):15-20. PubMed ID: 15596954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation-the final frontier.
    Govindan M; Savelieva I; Catanchin A; Camm AJ
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):36S-50S. PubMed ID: 20940451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation).
    Groenveld HF; Tijssen JG; Crijns HJ; Van den Berg MP; Hillege HL; Alings M; Van Veldhuisen DJ; Van Gelder IC;
    J Am Coll Cardiol; 2013 Feb; 61(7):741-8. PubMed ID: 23410544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhythm control strategies and the role of antiarrhythmic drugs in the management of atrial fibrillation: focus on clinical outcomes.
    Bunch TJ; Gersh BJ
    J Gen Intern Med; 2011 May; 26(5):531-7. PubMed ID: 21108047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial fibrillation: what have recent trials taught us regarding pharmacologic management of rate and rhythm control?
    Reiffel JA
    Pacing Clin Electrophysiol; 2011 Feb; 34(2):247-59. PubMed ID: 21091736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.